MT Højgaard Holding A/S
29.1.2021 15:48:38 CET | Globenewswire | Press release
MT Højgaard Holding’s business unit, Enemærke & Petersen, has won the Funen-based social housing organisation Civica’s tender for a multi-year strategic partnership for renovation and construction projects comprising an estimated total value of DKK 3 billion. It is expected that Civica will enter into the agreement with Enemærke & Petersen after the end of the standstill period.
Enemærke & Petersen will perform the work in close cooperation with Erik Arkitekter A/S, Oluf Jørgensen A/S, SWECO Danmark A/S, Kant Arkitekter and Bymunch By- og Landskabsdesign ApS.
The tender does not change MT Højgaard Holding’s previously announced 2020 outlook, but it will contribute significantly to the group’s long-term, sustainable development in the coming years. MT Højgaard Holding will publish its annual report 2020 and the outlook for 2021 on 24 February 2021.
Additional information:
CEO Morten Hansen and CFO Martin Solberg can be contacted on telephone +45 22 70 93 65.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Fast Ejendom Danmark29.3.2026 18:17:55 CEST | Pressemeddelelse
Aktietilbagekøbsprogram
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
